Agomelatine: a new opportunity to reduce neuropathic pain. Preclinical evidence. - Université Clermont Auvergne Access content directly
Journal Articles Pain Year : 2017

Agomelatine: a new opportunity to reduce neuropathic pain. Preclinical evidence.

No file

Dates and versions

hal-01659567 , version 1 (08-12-2017)

Identifiers

Cite

Chouki Chenaf, Eric Chapuy, Frédéric Libert, Fabien Marchand, Christine Courteix, et al.. Agomelatine: a new opportunity to reduce neuropathic pain. Preclinical evidence.. Pain, 2017, 158 (1), pp.149 - 160. ⟨10.1097/j.pain.0000000000000738⟩. ⟨hal-01659567⟩

Collections

PRES_CLERMONT ND
152 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More